You are here: Industry Insights > cancer

News List

Breast Cancer Surgery + Another Procedure Ups Complications drugs
August 09, 2019
Patients undergoing surgery for breast cancer, who simultaneously have either a plastic or gynecologic procedure, have greater postoperative complications, according to a study published online in The Breast Journal.
Bone Health Management Key in Childhood Cancer Survivors drugs
August 07, 2019
As part of a literature review, published in the June issue of the Annals of Oncology, recommendations are presented for the management of bone health in survivors of childhood cancer.
Innovent and Shenogen study Tyvyt-SNG1005 combination for cancer pharmaceutical-technology
August 07, 2019
Innovent Biologics and Shenogen Pharma Group have signed a collaboration agreement to evaluate the combination therapy of Innovent’s Tyvyt with Shenogen’s SNG1005, in patients with advanced cancer.
USPSTF Reaffirms Recs Against Screening for Pancreatic Cancer drugs
August 07, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for pancreatic adenocarcinoma as the potential benefits do not outweigh the potential harms.
Common Prostate Cancer Treatment Anti-Androgens May Increase Risk of Fatal Heart Condition drugs
August 06, 2019
Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment.
Psychologic Distress Linked to Cervical Cancer Mortality drugs
August 05, 2019
A clinical diagnosis of stress-related disorders or an occurrence of stressful life events around the time of cervical cancer diagnosis is associatedwith an ...
Finances Affect Women's Choice of Breast Cancer Treatment: Study drugs
August 05, 2019
Cost often influences breast cancer patients' decisions about surgery, even if they have good incomes and insurance, a new study finds.
First Patient Dosed with the Affinity-Tailored T-Cell-adaptor in Phase I Study americanpharmaceuticalreview
August 01, 2019
GEMoaB GmbH announced the dosing of the first patient in a Phase I open-label, dose escalation study of GEM3PSCA, an Affinity-Tailored Adapter for T-Cells (ATAC). The bispecific antibody binds to the CD3-Receptor on T-cells and prostate stem cell antigen
Vitamin A Linked to Lower Odds of Common Skin Cancer drugs
August 01, 2019
Wondering if you can do more than slap on some sunscreen to prevent?skin cancer? A new study suggests that getting more vitamin A may help.
FDA Approves Nubeqa (darolutamide) for Men with Non-Metastatic Castration-Resistant Prostate Cancer drugs
August 01, 2019
The U.S. Food and Drug Administration (FDA) today approved Nubeqa??(darolutamide), an androgen receptor inhibitor (ARi)...